<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04238312</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-10556</org_study_id>
    <nct_id>NCT04238312</nct_id>
  </id_info>
  <brief_title>Respiratory Biofeedback Device and Reduction of Dental Anxiety Associated With Local Anesthesia in Children</brief_title>
  <official_title>The Effect of a Respiratory Biofeedback Device on Reduction of Dental Anxiety Associated With Local Anesthesia in Children: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nourhan M.Aly</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alexandria</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to investigate the effect of a respiratory biofeedback device
      (RESPeRATE TM) in reduction of preoperative anxiety in children undergoing dental procedures
      under local anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was a randomized controlled clinical trial. A total of 110 anxious pediatric dental
      patients, of age range 7-12 years, were selected from the Pediatric Dentistry and Dental
      Public Health Department, Faculty of Dentistry, Alexandria University, Egypt, after securing
      parental informed consents. Children were chosen according to the Faces version of Modified
      Child Dental Anxiety Scale scoring 26 or more.

      The participants will be randomly allocated into 2 groups: Group I: Study group and Group II:
      Control group. The patients of group I (Study group) will undergo a session of biofeedback
      regulation by using &quot;RESPeRATETM&quot; as an anxiety reducing method. Group II patients will be
      managed by a routine behavioral management technique &quot;Tell,show,do&quot;. Local anesthesia
      injection will be administered to the child, after which heart rate measurement and salivary
      sample for salivary amylase analysis will be repeated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 15, 2018</start_date>
  <completion_date type="Actual">January 15, 2020</completion_date>
  <primary_completion_date type="Actual">October 18, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study will be a randomized controlled clinical trial, with 1:1 allocation ratio.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>The operator will not be blinded to the treatment as the RESPeRATE™ will be used for the study group while the device will not be applied to the control group.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>baseline</time_frame>
    <description>A finger pulse oximeter will be placed on the finger of the left hand of the child.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>after 5 minutes</time_frame>
    <description>A finger pulse oximeter will be placed on the finger of the left hand of the child.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxygen saturation</measure>
    <time_frame>baseline</time_frame>
    <description>Oxygen saturation will be monitored using an oximeter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxygen saturation</measure>
    <time_frame>after 5 minutes</time_frame>
    <description>Oxygen saturation will be monitored using an oximeter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Behavior Evaluation</measure>
    <time_frame>baseline</time_frame>
    <description>using Frankl scale (ranges from 1-4); 1: Definitely negative, 2: negative, 3:positive and 4: definitely positive</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Behavior Evaluation</measure>
    <time_frame>after 1 week during follow-up sessions</time_frame>
    <description>using Frankl scale (ranges from 1-4); 1: Definitely negative, 2: negative, 3:positive and 4: definitely positive</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>RESPeRATE™</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RESPeRATE™: 2breathe Tech. Ltd., Eshtaol, Israel. The device includes a belt-type respiration sensor worn outside of the clothing that is placed around the torso. It is connected to a computerized box that generates musical patterns listened through an earbud. The device guides the user interactively to slow breathing with a relatively prolonged expiration.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tell, Show and Do technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RESPeRATE™</intervention_name>
    <description>Fifty-five anxious pediatric dental patients received a breathing session of 10 minutes, using the RESPeRATE™ device.</description>
    <arm_group_label>RESPeRATE™</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tell, Show and Do technique</intervention_name>
    <description>Fifty-five anxious pediatric dental patients received a traditional behavior management technique (Tell-Show-Do).</description>
    <arm_group_label>Tell, Show and Do technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal healthy children (physical status ASA I &amp; II).

          -  Scoring 26 or more on faces version of modified child dental anxiety scale (MCDASf).

          -  Dental procedure requiring local anesthesia.

          -  Completion of a parental consent to participate in the study.

        Exclusion Criteria:

          -  Children on anxiolytic medication or using any medication directly related to
             emotional or cognitive function.

          -  Children with special needs.

          -  Children on medications that specifically agonize or antagonize alpha- or
             beta-adrenergic processes.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Zeitoun, M.Sc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Dentistry, Alexandria University, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amani Khalil, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Dentistry, Alexandria University, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nadia Wahba, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Dentistry, Alexandria University, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed IS Ahmed, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Medicine, Alexandria University, Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Dentistry, Alexandria University</name>
      <address>
        <city>Alexandria</city>
        <zip>21512</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Morarend QA, Spector ML, Dawson DV, Clark SH, Holmes DC. The use of a respiratory rate biofeedback device to reduce dental anxiety: an exploratory investigation. Appl Psychophysiol Biofeedback. 2011 Jun;36(2):63-70. doi: 10.1007/s10484-011-9148-z.</citation>
    <PMID>21365307</PMID>
  </reference>
  <reference>
    <citation>Howard KE, Freeman R. Reliability and validity of a faces version of the Modified Child Dental Anxiety Scale. Int J Paediatr Dent. 2007 Jul;17(4):281-8.</citation>
    <PMID>17559456</PMID>
  </reference>
  <reference>
    <citation>Chipps J. Psychological therapies for the management of chronic and recurrent pain in children and adolescents: A Cochrane review summary. Int J Nurs Stud. 2019 Aug 16:103393. doi: 10.1016/j.ijnurstu.2019.103393. [Epub ahead of print]</citation>
    <PMID>31519334</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 18, 2020</study_first_submitted>
  <study_first_submitted_qc>January 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2020</study_first_posted>
  <last_update_submitted>March 27, 2020</last_update_submitted>
  <last_update_submitted_qc>March 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Alexandria</investigator_affiliation>
    <investigator_full_name>Nourhan M.Aly</investigator_full_name>
    <investigator_title>Instructor of Dental Public Health and Statistician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

